INT64639

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.30
First Reported 1996
Last Reported 1996
Negated 0
Speculated 0
Reported most in Abstract
Documents 1
Total Number 1
Disease Relevance 0.30
Pain Relevance 0.38

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (Slc1a1) lyase activity (Ddc) intracellular (Ddc)
cellular amino acid metabolic process (Ddc) cytoplasm (Ddc)
Slc1a1 (Rattus norvegicus)
Ddc (Rattus norvegicus)
Pain Link Frequency Relevance Heat
antagonist 2 100.00 Very High Very High Very High
excitatory amino acid 1 100.00 Very High Very High Very High
Opioid 1 89.28 High High
Analgesic 2 88.72 High High
monoamine 2 77.12 Quite High
Eae 1 54.72 Quite High
Disease Link Frequency Relevance Heat
Disease 2 100.00 Very High Very High Very High
Parkinson's Disease 1 100.00 Very High Very High Very High
Muscle Rigidity 1 98.56 Very High Very High Very High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Excitatory amino acid receptor antagonists lead to marked suppression of parkinsonian-like symptoms in rodent and primate models of Parkinson's disease and are able to potentiate the ability of L-DOPA to reverse akinesia and ameliorate muscular rigidity displayed in these animal models.
Excitatory amino acid receptor Positive_regulation (potentiate) of L-DOPA associated with parkinson's disease, antagonist, disease, muscle rigidity and excitatory amino acid
1) Confidence 0.30 Published 1996 Journal J Neural Transm Section Abstract Doc Link 8811503 Disease Relevance 0.30 Pain Relevance 0.38

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox